National Institute of Mental Health; Notice of Closed Meetings, 77164 [2024-21588]
Download as PDF
<![CDATA[
77164
Federal Register / Vol. 89, No. 183 / Friday, September 20, 2024 / Notices
information are subject to review by
OMB under the PRA. The collections of
been approved by OMB as listed in the
following table:
OMB control
No.
21 CFR part; guidance; or FDA form
Topic
807, subpart E ............................................................................
814, subparts A through E .........................................................
814, subpart H ............................................................................
812 ..............................................................................................
860, subpart D ............................................................................
‘‘Requests for Feedback on Medical Device Submissions: The
Q-Submission Program and Meetings with Food and Drug
Administration Staff’’.
Premarket notification .................................................................
Premarket approval ....................................................................
Humanitarian Device Exemption ................................................
Investigational Device Exemption ..............................................
De Novo classification process ..................................................
Q-Submissions and Early Payor Feedback Request Programs
for Medical Devices.
Dated: September 17, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024–21575 Filed 9–19–24; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
ddrumheller on DSK120RN23PROD with NOTICES1
information in the following FDA
regulations, guidance, and forms have
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
BRAIN UG3/UH3 Novel Tools Review
Meeting.
Date: October 24, 2024.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health
Neuroscience Center 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Evon Abisaid, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
6001 Executive Boulevard, Rockville, MD
20852, (301) 827–0399 email: ereifejes@
mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Silvio O. Conte Centers for Basic
Neuroscience or Translational Mental Health
Research (P50).
VerDate Sep<11>2014
16:44 Sep 19, 2024
Jkt 262001
Date: October 30, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Rebecca Steiner Garcia,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
Neuroscience Center, 6001 Executive Blvd.,
Bethesda, MD 20892–9608 301–443–4525
email: steinerr@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel; Early
Phase Clinical Trials: Pharma/Device and K
Awards.
Date: October 31, 2024.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Regina Dolan-Sewell,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
Neuroscience Center, 6001 Executive Blvd.
Bethesda, MD 20852 (240) 796–6785 email:
regina.dolan-sewell@nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: September 17, 2024.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–21588 Filed 9–19–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01 Clinical
Trial Not Allowed).
Date: October 28, 2024.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G54,
Rockville, MD 20852 (Virtual Meeting).
Contact Person: Hitendra S. Chand, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G54, Rockville, MD
20852, (240) 627–3245, hiten.chand@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: September 16, 2024.
Lauren A. Fleck,
Program Analyst,Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–21502 Filed 9–19–24; 8:45 am]
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
BILLING CODE 4140–01–P
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
PO 00000
Frm 00090
Fmt 4703
Sfmt 9990
0910–0120
0910–0231
0910–0332
0910–0078
0910–0844
0910–0756
E:\FR\FM\20SEN1.SGM
20SEN1
]]>Agencies
[Federal Register Volume 89, Number 183 (Friday, September 20, 2024)]
[Notices]
[Page 77164]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-21588]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; BRAIN UG3/UH3 Novel Tools Review Meeting.
Date: October 24, 2024.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health Neuroscience Center 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Evon Abisaid, Ph.D., Scientific Review Officer,
Division of Extramural Activities, National Institute of Mental
Health, National Institutes of Health, 6001 Executive Boulevard,
Rockville, MD 20852, (301) 827-0399 email: [email protected].
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; Silvio O. Conte Centers for Basic Neuroscience or
Translational Mental Health Research (P50).
Date: October 30, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Rebecca Steiner Garcia, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Institute of
Mental Health, National Institutes of Health, Neuroscience Center,
6001 Executive Blvd., Bethesda, MD 20892-9608 301-443-4525 email:
[email protected].
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; Early Phase Clinical Trials: Pharma/Device and K
Awards.
Date: October 31, 2024.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Regina Dolan-Sewell, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Institute of
Mental Health, National Institutes of Health, Neuroscience Center,
6001 Executive Blvd. Bethesda, MD 20852 (240) 796-6785 email:
[email protected].
(Catalogue of Federal Domestic Assistance Program No. 93.242, Mental
Health Research Grants, National Institutes of Health, HHS)
Dated: September 17, 2024.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-21588 Filed 9-19-24; 8:45 am]
BILLING CODE 4140-01-P
